We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

SD BIOSENSOR

SD BIOSENSOR develops immunological and molecular diagnostics and blood glucose self-monitoring systems, glycated hem... read more Featured Products: More products

Download Mobile App




Performance Evaluated for Point-of-Care HbA1c Analyzer

By LabMedica International staff writers
Posted on 07 Jul 2015
Print article
The SD A1cCare point-of-care analyzer
The SD A1cCare point-of-care analyzer (Photo courtesy of SD BIOSENSOR)
Glycated hemoglobin (HbA1c) levels, which reflect the average plasma glucose concentration over the preceding three months, play a pivotal role in the diagnosis, assessment, and monitoring of diabetes.

The immediate feedback of HbA1c levels is highly effective for controlling plasma glucose levels and point-of-care (POC) instruments, characterized as fast, portable, and easy-to-use, have been shown to be suitable for providing rapid feedback of HbA1c levels.

Medical laboratory scientists at the Seoul National University College of Medicine (Republic of Korea) assessed the analytical performance of a newly developed POC HbA1c analyzer. To investigate the accuracy of the analyzer, they measured the deviation from the International Federation of Clinical Chemistry (IFCC) reference targets using two sets of 12 duplicate fresh venous whole blood specimens with a range of 33.3 mmol/mol to 91.3 mmol/mol in International System of Units (SI) units, or 5.2% to 10.5% in National Glycohemoglobin Standardization Program (NSGP) units.

The SD A1cCare analyzer (SD Biosensor, Inc.; Suwon, Korea), which utilizes an immunochromatography assay, was used to measures total hemoglobin and HbA1c levels via its optical system and calculates the percentage HbA1c. The SD A1cCare Test kit uses an anti-HbA1c antibody that is specific for the first few amino acid residues of the glycated N-terminus of the β-chain of hemoglobin A0. The scientists tested 150 residual specimens using both the SD A1cCare and the Variant II Turbo (Bio-Rad Laboratories, Inc.; Hercules, CA, USA) in 14 days.

The SD A1cCare POC HbA1c analyzer showed excellent precision, linearity and correlation with Variant II Turbo high-performance liquid chromatography (HPLC) and it showed excellent accuracy with IFCC targets. Deviations from IFCC targets at 30, 60, and 90 mmol/mol IFCC levels were − 1.95, − 1.85, and − 1.74 mmol/mol, respectively. The coefficients of variation based on EP9-A2 protocol were 2.6% in SI units and 1.8% in NGSP units.

The authors concluded that the SD A1cCare analyzer showed excellent precision, linearity, correlation with the Variant II Turbo analyzer, and accuracy with IFCC targets and therefore, it may be suitable for HbA1c assays in the POC setting and in small laboratories. The study was published in the June, 2015 issue of the journal Clinical Biochemistry.

Related Links:

Seoul National University College of Medicine 
SD Biosensor Inc.
Bio-Rad Laboratories 


Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Biological Indicator Vials
BI-O.K.
New
Auto Clinical Chemistry Analyzer
cobas c 703
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The study investigated D-dimer testing in patients who are at higher risk of pulmonary embolism (Photo courtesy of Adobe Stock)

D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism

Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.